Validation of serum biomarkers for detection of early-stage ovarian cancer
Authors:
- Feng SuFSFeng Su
- Malaika AmneusMAMalaika Amneus
- Michael BirrerMBMichael Birrer
- Terry RobinsTRTerry Robins
- Jenny KotlermanJKJenny Kotlerman
- Srinivasa ReddySRSrinivasa Reddy
- Robin Farias-EisnerRFRobin Farias-Eisner
- 1 June 2009
- journal article
- research article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 200 (6) , 639.e1-639.e5
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- The early detection of ovarian cancer: from traditional methods to proteomics. Can we really do better than serum CA-125?American Journal of Obstetrics and Gynecology, 2008
- Diagnostic Markers for Early Detection of Ovarian CancerClinical Cancer Research, 2008
- Validation of Candidate Serum Ovarian Cancer Biomarkers for Early DetectionBiomarker Insights, 2007
- Characterization of serum biomarkers for detection of early stage ovarian cancerProteomics, 2005
- Three Biomarkers Identified from Serum Proteomic Analysis for the Detection of Early Stage Ovarian CancerCancer Research, 2004
- Identification of biomarkers for ovarian cancer using strong anion-exchange ProteinChips: Potential use in diagnosis and prognosisProceedings of the National Academy of Sciences, 2003
- Three-Dimensional Power Doppler Ultrasound Improves the Diagnostic Accuracy for Ovarian Cancer PredictionGynecologic Oncology, 2001
- Screening for ovarian cancer: a pilot randomised controlled trialThe Lancet, 1999
- CA 125: The past and the FutureThe International Journal of Biological Markers, 1998
- Prevalence screening for ovarian cancer in postmenopausal women by CA 125 measurement and ultrasonography.BMJ, 1993